MedPath

绿叶嘉奥制药石家庄有限公司

Ownership
-
Established
2022-06-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Rotigotine Microspheres for Injection

Product Name
注射用罗替高汀微球
Approval Number
国药准字H20240027
Approval Date
Jun 18, 2024
NMPA

Rotigotine Microspheres for Injection

Product Name
注射用罗替高汀微球
Approval Number
国药准字H20240025
Approval Date
Jun 18, 2024
NMPA

Rotigotine Microspheres for Injection

Product Name
注射用罗替高汀微球
Approval Number
国药准字H20240026
Approval Date
Jun 18, 2024
NMPA

Rotigotine Microspheres for Injection

Product Name
注射用罗替高汀微球
Approval Number
国药准字H20240028
Approval Date
Jun 18, 2024
NMPA

Paliperidone Palmitate Injection

Product Name
棕榈酸帕利哌酮注射液
Approval Number
国药准字H20243895
Approval Date
Jun 4, 2024
NMPA

Paliperidone Palmitate Injection

Product Name
棕榈酸帕利哌酮注射液
Approval Number
国药准字H20243897
Approval Date
Jun 4, 2024
NMPA

Paliperidone Palmitate Injection

Product Name
棕榈酸帕利哌酮注射液
Approval Number
国药准字H20243898
Approval Date
Jun 4, 2024
NMPA

Paliperidone Palmitate Injection

Product Name
棕榈酸帕利哌酮注射液
Approval Number
国药准字H20243894
Approval Date
Jun 4, 2024
NMPA

Paliperidone Palmitate Injection

Product Name
棕榈酸帕利哌酮注射液
Approval Number
国药准字H20243896
Approval Date
Jun 4, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.